RTH258 6 mg in patients with retina damage such as growth of abnormal blood vessels RTH258 6 mg em doentes com danos na retina tais como crescimento anormal de vasos sanguíneos

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-004886-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate that RTH258 6 mg is not inferior to aflibercept 2 mg with respect to the change in best-corrected visual acuity (BCVA) from Baseline to Week 48


Critère d'inclusion

  • Exudative senile macular degeneration of retina